the-left-pneumonectomy-combined-with-monocrotaline-or-sugen-as-model

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

In this protocol, we detail the correct procedural steps and necessary precautions to successfully perform a left pneumonectomy and induce PAH in rats ...

Icahn School of Medicine at Mount Sinai

Advances in DNA- and RNA-based technologies have made gene therapy suitable for many lung diseases, especially those that are hereditary. The main objective of gene therapy is to deliver an adequate amount of gene construct to the intended target cell, achieve stable transduction in target cells, and to produce a clinically therapeutic effect. This review focuses on the cellular organization in the normal lung and how gene therapy targets the specific cell types that are affected by pulmonary disorders caused by genetic mutations. Furthermore, it examines the pulmonary barriers that can compromise the absorption and transduction of viral vectors and genetic agents by the lung. Finally, it discusses the advantages and limitations of direct intra-tracheal gene delivery with different viral vectors in small and large animal models and in clinical trials.

Sarah M. Gubara

Cardiovascular Research Center,
Department of Cardiology,
Cardiovascular Research Center, Department of Cardiology

Icahn School of Medicine at Mount Sinai

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Sarah M. Gubara

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Cardiovascular Research Center,Department of Cardiology,Cardiovascular Research Center, Department of Cardiology

Icahn School of Medicine at Mount Sinai

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Cardiovascular Research Center,
Department of Cardiology,
Cardiovascular Research Center, Department of Cardiology